← Back to Clinical Trials
Recruiting NCT06086561

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

Trial Parameters

Condition Hydrocephalus
Sponsor Rhaeos, Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 130
Sex ALL
Min Age 5 Years
Max Age 80 Years
Start Date 2023-11-17
Completion 2025-12
Interventions
Thermal Anisotropy Measurement Device

Brief Summary

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to acquire longitudinal data.

Eligibility Criteria

Inclusion Criteria: 1. At least one existing ventricular CSF shunt (functional or non-functional, including "virtual off" and ligated, orphaned, abandoned, tied-off, or fractured distal catheters) 2. Region(s) of intact skin overlying at least one unambiguously identifiable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device 3. Available for remote and in-person follow-up during the 30-day measurement period (for subjects using the study device at home) 4. Subject is expected to remain in an inpatient setting for sufficient time to complete all required study device measurements (for subjects using the device in an inpatient hospital setting) 5. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 6. Subject or caregiver is able to clearly communicate and document information and shunt symptoms in English 7. Verbal assent

Related Trials